Clinical progression and outcome of patients with monoclonal B-cell lymphocytosis

References

• Marti G E, Rawstron A C, Ghia P, Hillmen P, Houlston R S, Kay N, et al. Diagnostic criteria for monoclonal B-cell lymphocytosis. Br J Haematol 2005; 130: 325–332
   PubMed Web of Science ®Google Scholar
• Cheson B D, Bennett J M, Grever M, Kay N, Keating M J, O'Brien S, et al. National Cancer Institute-sponsored Working Group guidelines for chronic lymphocytic leukemia: revised guidelines for diagnosis and treatment. Blood 1996; 87: 4990–4997
   PubMed Web of Science ®Google Scholar
• Chanarin I, Tidmarsh E, Harrisingh D, Skacel P O. Significance of lymphocytosis in adults. Lancet 1984; 2: 897–899
   PubMed Web of Science ®Google Scholar
• Binet J L, Caligaris-Cappio F, Catovsky D, Cheson B, Davis T, Dighiero G, et al. Perspectives on the use of new diagnostic tools in the treatment of chronic lymphocytic leukemia. Blood 2006; 107: 859–861
   PubMed Web of Science ®Google Scholar
• Rawstron A, Hillmen P, Houlston R. Clonal lymphocytes in persons without known chronic lymphocytic leukemia (CLL): implications of recent findings in family members of CLL patients. Semin Hematol 2004; 41: 192–200
   PubMed Web of Science ®Google Scholar
• Kay N, Hamblin T, Jelinek D. Chronic lymphocytic leukemia. The American Society of Hematology Education Program Book, V C Broudy, J L Abkowitz, J M Vose. American Society of Hematology. 2002; 193–213
   Google Scholar
• Rai K R, Chiorazzi N. Determining the clinical course and outcome in chronic lymphocytic leukemia. N Engl J Med 2003; 348: 1797–1799
   PubMed Web of Science ®Google Scholar
• Ghia P, Prato G, Scielzo C, Stella S, Geuna M, Guida G, et al. Monoclonal CD5+ and CD5− B-lymphocyte expansions are frequent in the peripheral blood of the elderly. Blood 2004; 103: 2337–2342
   PubMed Web of Science ®Google Scholar
• Han T, Ozer H, Gavigan M, Gajera R, Minowada J, Bloom M L, et al. Benign monoclonal B cell lymphocytosis—a benign variant of CLL: clinical, immunologic, phenotypic, and cytogenetic studies in 20 patients. Blood 1984; 64: 244–252
   PubMed Web of Science ®Google Scholar
• Faguet G B, Agee J F, Marti G E. Clone emergence and evolution in chronic lymphocytic leukemia: characterization of clinical, laboratory and immunophenotypic profiles of 25 patients. Leukemia and Lymphoma 1992; 6: 345–356
   Web of Science ®Google Scholar
• Galton D AG. The pathogenesis of chronic lymphocytic leukemia. Can Med Assoc J 1966; 94: 1005–1010
   PubMed Web of Science ®Google Scholar
• Montserrat E, Sanchez-Bisono J, Vinolas N, Rozman C. Lymphocyte doubling time in chronic lymphocytic leukaemia: analysis of its prognostic significance. Br J Haematol 1986; 62: 567–575
   PubMed Web of Science ®Google Scholar
• Muller-Hermelink H K, Montserrat E, Catovsky D, Harris N L. Chronic lymphocytic leukemia/small lymphocytic lymphoma. World Health Organization Classification of Tumors; Pathology & Genetics; Tumors of Haematopoietic and Lymphoid Tissues, E S Jaffe, N L Harris, H Stein, J Vardiman. IARC Press, Lyon 2001
   Google Scholar
• Chiorazzi N, Rai K R, Ferrarini M. Chronic lymphocytic leukemia. N Engl J Med 2005; 352: 804–815
   PubMed Web of Science ®Google Scholar
• Mandelli F, De Rossi G, Mancini P, Alberti A, Cajozzo A, Grignani F, et al. Prognosis in chronic lymphocytic leukemia: a retrospective multicentric study from the GIMEMA group. J Clin Oncol 1987; 5: 398–406
   PubMed Web of Science ®Google Scholar
• Rozman C, Montserrat E, Feliu E, Granena A, Marin P, Nomdedeu B, et al. Prognosis of chronic lymphocytic leukemia: a multivariate survival analysis of 150 cases. Blood 1982; 59: 1001–1005
   PubMed Web of Science ®Google Scholar
• Wang C, Amato D, Rabah R, Zheng J, Fernandes B. Differentiation of monoclonal B lymphocytosis of undetermined significance (MLUS) and chronic lymphocytic leukemia (CLL) with weak CD5 expression from CD5(−) CLL. Leuk Res 2002; 26: 1125–1129
   PubMed Web of Science ®Google Scholar
• Aguilar-Santelises M, Loftenius A, Ljungh C, Svenson S B, Andersson B, Mellstedt H, et al. Serum levels of helper factors (IL-1 alpha, IL-1 beta and IL-6), T-cell products (sCD4 and sCD8), sIL-2R and beta 2-microglobulin in patients with B-CLL and benign B lymphocytosis. Leuk Res 1992; 16: 607–613
   PubMed Web of Science ®Google Scholar
• Aman P, Mellstedt H. The leukemic B-cell population of patients with monoclonal lymphocytosis of undetermined significance (MLUS) are functionally distinct from the chronic lymphocytic leukemia (CLL) derived cell population. Leuk Res 1991; 15: 715–719
   PubMed Web of Science ®Google Scholar
• Garcia C, Rosen A, Kimby E, Aguilar-Santelises M, Jondal M, Bjorkhilm M, et al. Higher T-cell imbalance and growth factor receptor expression in B-cell chronic lymphocytic leukemia (B-CLL) as compared to monoclonal B-cell lymphocytosis of undetermined significance (B-MLUS). Leuk Res 1989; 13: 31–37
   PubMed Web of Science ®Google Scholar
• Garcia C A, Rosen A, Aguilar-Santelises M, Jondal M, Mellstedt H. Higher proliferative response in B-chronic lymphocytic leukemia (B-CLL) as compared to B-monoclonal lymphocytosis of undetermined significance (B-MLUS) after stimulation with Staphylococcus aureus and anti-CD40 monoclonal antibodies. Leuk Res 1993; 17: 933–939
   PubMed Web of Science ®Google Scholar
• Kimby E, Mellstedt H, Bjorkholm M, Holm G. Clonal cell surface structures related to differentiation, activation and homing in B-cell chronic lymphocytic leukemia and monoclonal lymphocytosis of undetermined significance. Eur J Haematol 1989; 43: 452–459
   PubMed Web of Science ®Google Scholar
• Rawstron A C. Prevalence and characteristics of monoclonal B-cell lymphocytosis (MBL) in healthy individuals and the relationship with clinical disease. J Biol Regul Homeost Agents 2004; 18: 155–160
   PubMed Web of Science ®Google Scholar
• Rawstron A C, Green M J, Kuzmicki A, Kennedy B, Fenton J A, Evans P A, et al. Monoclonal B lymphocytes with the characteristics of “indolent” chronic lymphocytic leukemia are present in 3.5% of adults with normal blood counts. Blood 2002; 100: 635–639
   PubMed Web of Science ®Google Scholar